CDIS

Dolbey Introduces the Next Level in CDI Intelligence with CDI Alerts at ACDIS 2023

Retrieved on: 
Tuesday, May 9, 2023

CHICAGO, May 9, 2023 /PRNewswire/ -- Dolbey is unveiling their newest innovation, CDI Alerts™, at the 2023 ACDIS National Conference at the Hyatt Regency, Chicago, May 8-11.

Key Points: 
  • CHICAGO, May 9, 2023 /PRNewswire/ -- Dolbey is unveiling their newest innovation, CDI Alerts™, at the 2023 ACDIS National Conference at the Hyatt Regency, Chicago, May 8-11.
  • CDI Alerts is an add-on feature for the already robust Fusion CDI software, used by hospitals' clinical documentation integrity staff (CDIS) to assist in capturing the most accurate documentation possible.
  • "Our new CDI Alerts are unmatched in the industry and present a significant improvement in the tools available to clinical documentation integrity programs."
  • Together, Fusion CAC and Fusion CDI with CDI Alerts brings an unparalleled level of productivity and precision to the business of CDI.

LMN Architects Celebrates the Design and Construction of the New School of Computer, Data & Information Sciences Building at the University of Wisconsin

Retrieved on: 
Wednesday, April 26, 2023

Seattle, April 26, 2023 (GLOBE NEWSWIRE) -- LMN Architects is pleased to unveil the design of the new School of Computer, Data & Information Sciences (CDIS) building at the University of Wisconsin–Madison.

Key Points: 
  • Seattle, April 26, 2023 (GLOBE NEWSWIRE) -- LMN Architects is pleased to unveil the design of the new School of Computer, Data & Information Sciences (CDIS) building at the University of Wisconsin–Madison.
  • UW–Madison has commissioned LMN Architects and Kahler Slater to design a 342,990 SFT interdisciplinary academic building to establish a new tech corridor on campus and in the state of Wisconsin.
  • “There is no place on campus – or in modern society – where computing is not relevant” says Tom Erickson, CDIS founding director.
  • The university celebrated the groundbreaking ceremony on April 25, 2023, and the project is expected to be completed in 2025.

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023

Retrieved on: 
Thursday, January 26, 2023

SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2022.

Key Points: 
  • SG&A expenses improved to 20.5 percent of revenue in the quarter, compared with 20.7 percent in the same period of the prior year.
  • The dividend will have a record date of February 9, 2023, payable on March 16, 2023.
  • ResMed has received a waiver from the ASX’s settlement operating rules, which will allow ResMed to defer processing conversions between its common stock and CDI registers from February 8, 2023, through February 9, 2023, inclusive.
  • ResMed will discuss its second-quarter fiscal year 2023 results on its webcast at 1:30 p.m. U.S. Pacific Time today.

AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders

Retrieved on: 
Tuesday, December 13, 2022

VALENCIA, Calif. and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced the results of its 2022 Annual Meeting of Stockholders, which was held virtually on December 12, 2022 (United States) (being December 13, 2022 in Australia).

Key Points: 
  • VALENCIA, Calif. and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced the results of its 2022 Annual Meeting of Stockholders, which was held virtually on December 12, 2022 (United States) (being December 13, 2022 in Australia).
  • The voting results of the Annual Meeting of Stockholders for the purposes of ASX Listing Rule 3.13.2 are attached to this announcement.
  • Authorized for release by the Chief Executive Officer of AVITA Medical, Inc.
    AVITA Medical® is a regenerative medicine company leading the development and commercialization of devices and autologous cellular therapies for skin restoration.
  • This press release was authorized by the review committee of AVITA Medical, Inc.

Patriot Battery Metals Commences Trading on the ASX

Retrieved on: 
Tuesday, December 6, 2022

The shares of Patriot Battery Metals will trade under the ticker PMT and will be settled in the form of CHESS Depositary Interests (‘CDIs’) at a ratio of 10 CDIs to 1 share.

Key Points: 
  • The shares of Patriot Battery Metals will trade under the ticker PMT and will be settled in the form of CHESS Depositary Interests (‘CDIs’) at a ratio of 10 CDIs to 1 share.
  • Blair Way, Company President, CEO and Director, comments: “It is great to be trading on the ASX.
  • With the ASX listing blackout behind us I look forward to getting back to our normal news flow providing progress updates and assay results.
  • About Patriot Battery Metals Inc.
    Patriot Battery Metals Inc. is a mineral exploration company focused on the acquisition and development of mineral properties containing battery, base, and precious metals.

Patriot Battery Metals ASX Listing Update

Retrieved on: 
Thursday, December 1, 2022

The Company has received approval, subject to the usual conditions, from the ASX to Patriot's admission to the Official List and to the Official Quotation of Patriot's CHESS Depository Interests (CDIs).

Key Points: 
  • The Company has received approval, subject to the usual conditions, from the ASX to Patriot's admission to the Official List and to the Official Quotation of Patriot's CHESS Depository Interests (CDIs).
  • Patriot is working with ASX to meet the listing conditions and it is expected that trading in Patriot's CDIs (assigned a code of "PMT") on the ASX will commence on a normal settlement basis on December 7, 2022 (Australian time).
  • Upon completion of the ASX listing the Company expects to receive and review a backlog of assay results, with further announcements expected over the coming weeks.
  • About Patriot Battery Metals Inc.
    Patriot Battery Metals Inc. is a mineral exploration company focused on the acquisition and development of mineral properties containing battery, base, and precious metals.

Date of settlement of the Share Element of the Special Dividend

Retrieved on: 
Tuesday, June 14, 2022

On 14 December 2021, the Non-conflicted DMGT Directors declared a Special Dividend, comprised of a Cash Element and a Share Element, to all shareholders on the register of members of DMGT as at 6.00pm UK time on 16 December 2021.

Key Points: 
  • On 14 December 2021, the Non-conflicted DMGT Directors declared a Special Dividend, comprised of a Cash Element and a Share Element, to all shareholders on the register of members of DMGT as at 6.00pm UK time on 16 December 2021.
  • The Share Element is comprised of DMGTs holding of shares (Cazoo Shares) in Cazoo Group Ltd (Cazoo), equivalent to 0.5749 shares in Cazoo per DMGT share, subject to rounding.
  • At its declaration, settlement of the Share Element was expected to occur in the first half of 2022 and the timing was uncertain due to it being subject to US securities law restrictions.
  • Additional information on the Share Element will be provided to former DMGT Shareholders in the Information Document in relation to the Share Element of the Special Dividend, which is being published with this announcement.

Almonty Raises a Further A$2.12m in Private Placement to Advance Ongoing Growth Opportunities

Retrieved on: 
Tuesday, June 7, 2022

The Placement CDIs issued under the Placement will rank equally with existing CDIs and Common Shares on issue.

Key Points: 
  • The Placement CDIs issued under the Placement will rank equally with existing CDIs and Common Shares on issue.
  • The closing of the Placement is subject to receipt of all necessary regulatory approvals, including the acceptance by the TSX and ASX.
  • Lazarus Corporate Finance Pty Ltd acted as Lead Manager to the Placement and will be paid a total fee of 6% of the gross proceeds raised in the Placement.
  • Current Almonty Director Mr Andrew Frazer is also the managing director of Lazarus, the Lead Manager for the Placement.

Update on expected timing of settlement of the Share Element of the Special Dividend

Retrieved on: 
Thursday, May 26, 2022

The Share Element is comprised of DMGTs holding of shares (Cazoo Shares) in Cazoo Group Ltd (Cazoo), equivalent to approximately 0.5749 shares in Cazoo per DMGT share.

Key Points: 
  • The Share Element is comprised of DMGTs holding of shares (Cazoo Shares) in Cazoo Group Ltd (Cazoo), equivalent to approximately 0.5749 shares in Cazoo per DMGT share.
  • At its declaration, settlement of the Share Element was expected to occur in the first half of 2022 and the timing was uncertain due to it being subject to US securities law restrictions.
  • On 31 March 2022, DMGT provided an update on the likely timing of settlement including that settlement could only occur if Cazoos registration statement on Form F-1 was effective and usable.
  • Additional information on the Share Element will be provided to former DMGT Shareholders in the Information Document in relation to the Share Element of the Special Dividend, which is expected to be published in advance of the settlement date, once that date is known.

Update on expected timing of settlement of the Share Element of the Special Dividend

Retrieved on: 
Friday, May 6, 2022

The Share Element is comprised of DMGTs holding of shares (Cazoo Shares) in Cazoo Group Ltd (Cazoo), equivalent to approximately 0.5749 shares in Cazoo per DMGT share.

Key Points: 
  • The Share Element is comprised of DMGTs holding of shares (Cazoo Shares) in Cazoo Group Ltd (Cazoo), equivalent to approximately 0.5749 shares in Cazoo per DMGT share.
  • At its declaration, settlement of the Share Element was expected to occur in the first half of 2022 and the timing was uncertain due to it being subject to US securities law restrictions.
  • On 31 March 2022, DMGT provided an update that the timing remained uncertain but that the settlement was expected to occur in May 2022.
  • DMGT will provide a further update, including the expected date of settlement, once Cazoos registration statement is effective and usable.